Depressed patients show evidence of both proinflammatory changes and neurophysiological abnormalities such as increased amygdala reactivity and volumetric decreases of the hippocampus and ventromedial prefrontal cortex (vmPFC). However, very little is known about the relationship between inflammation and neuroimaging abnormalities in mood disorders. A whole genome expression analysis of peripheral blood mononuclear cells yielded 12 protein-coding genes (ADM, APBB3, CD160, CFD, CITED2, CTSZ, IER5, NFKBIZ, NR4A2, NUCKS1, SERTAD1, TNF) that were differentially expressed between 29 unmedicated depressed patients with a mood disorder (8 bipolar disorder, 21 major depressive disorder) and 24 healthy controls (HCs). Several of these genes have been implicated in neurological disorders and/or apoptosis. Ingenuity Pathway Analysis yielded two genes networks, one centered around TNF with NFKb, TGFb, and ERK as connecting hubs, and the second network indicating cell cycle and/or kinase signaling anomalies. fMRI scanning was conducted using a backward-masking task in which subjects were presented with emotionally-valenced faces. Compared with HCs, the depressed subjects displayed a greater hemodynamic response in the right amygdala, left hippocampus, and the ventromedial prefrontal cortex to masked sad versus happy faces. The mRNA levels of several genes were significantly correlated with the hemodynamic response of the amygdala, vmPFC and hippocampus to masked sad versus happy faces. Differentially-expressed transcripts were significantly correlated with thickness of the left subgenual ACC, and volume of the hippocampus and caudate. Our results raise the possibility that molecular-level immune dysfunction can be mapped onto macro-level neuroimaging abnormalities, potentially elucidating a mechanism by which inflammation leads to depression.
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Background
Extant data indicate that people with mood disorders who are currently depressed display abnormalities of immune function including chronic activation of the innate immune system (Dantzer et al., 2008; Maes, 2008; Miller et al., 2009; Drexhage et al., 2010) . These data take the form of (a) elevated levels of proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin 6 (IL6) in the serum or plasma of patients with major depressive disorder (MDD) (Maes, 1999; Howren et al., 2009; Dowlati et al., 2010) , (b) the differential expression of immune-related genes in the monocytes of people with bipolar disorder (BD) (Padmos et al., 2008) , (c) the anti-inflammatory effect of antidepressant medication (De Berardis et al., 2010) , (d) the induction of depression in up to 40% of cancer and hepatitis C patients during treatment with interferon alpha (INFa) (Capuron and Miller, 2004) , (e) the induction of depressive symptoms in healthy individuals administered endotoxin (Eisenberger et al., 2009) or typhoid vaccine (Harrison et al., 2009a) , (f) the epidemiological association between mood disorders and diseases with an autoimmune or
